• Alveolar Rhabdomyosarcoma (ARMS), 13q14 (FOXO1 or FKHR) Rearrangement, FISH, Tissue
  • Post-transplant Rejection Assessment, Kidney, Heart, Lung (Prospera™, AlloSure®, VitaGraft™/GraftAssureDx)
  • Platelet Antigen Genotyping Panel
  • UBA1 Gene Mutations Analysis for Autoinflammatory diseases (VEXAS syndrome)
  • Tramadol, Urine
  • Folic Acid (Folate), RBC
  • Protean BioDiagnostics Lung HDPCR™ for Non-Small Cell Lung Cancer (NSCLC)
  • Thyroxine, Free (FT4)
  • Lymphocytic Choriomeningitis (LCM) Virus Antibody, IgG
  • Pseudoephedrine, Urine
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Endometrial Carcinoma Gene Mutation Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Endometrial Carcinoma Gene Mutation Panel, NGS
Medical Test

Interpretation
Access to Endometrial Carcinoma Gene Mutation Panel, NGS is restricted.
Loading...